首页 正文

In silico development of new PET radiopharmaceuticals from mTOR inhibitors

{{output}}
Rapamycin (or sirolimus) is a macrolide that has shown to be useful as an immunosuppressant and that was studied in metabolic, neurological, or genetic disorders. Rapamycin is a specific natural inhibitor of the mechanistic target of rapamycin (mTOR) that is a... ...